← Open Payments lookup

DEBORAH MILES: Open Payments

NPI 1245200468 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$996 in 26 payments from 10 companies in 2025. Trend: 2023 $1,175 · 2024 $671 · 2025 $996

Food & beverage: $996
CompanyPaymentsAmount
Novo Nordisk Inc6$235
AstraZeneca Pharmaceuticals LP5$218
Otsuka America Pharmaceutical, Inc.7$153
ABBVIE INC.1$122
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$92
Lilly USA, LLC1$90
Axsome Therapeutics, Inc.1$38
GlaxoSmithKline, LLC.2$30
Amgen Inc.1$15
Phathom Pharmaceuticals, Inc.1$3

Products named: AIRSUPRA, REXULTI, Wegovy, QULIPTA, CAPLYTA, ZEPBOUND, Ozempic, Auvelity.

Industry payments across AR — which companies pay providers there.